Home Healthcare Market Size, Share & Trends Analysis Report By Component (Equipment, Services), By Indication (Cardiovascular Disorder & Hypertension, Diabetes & Kidney Disorders), By Region,- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2025-2034

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.2. Market Definitions

1.2.1. Component

1.2.2. Indication

1.3. Regional Scope

1.4. Estimates and Forecast Timeline

1.5. Information Procurement

1.5.1. Purchased Database

1.5.2. Internal Database

1.5.3. Secondary Sources & Third-Party Perspectives

1.5.4. Primary Research

1.5.5. Details of Primary Research

1.6. Information Analysis

1.6.1. Data Analysis Models

1.7. Market Formulation & Data Visualization

1.7.1. Commodity Flow Analysis

1.7.1.1. Approach 1: Commodity flow approach

1.7.1.2. Approach 2: Country wise market estimation using bottom up approach

1.8. Data Validation & Publishing

1.9. Global Market: CAGR Calculation

1.10. List of Secondary Sources

1.11. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Snapshot

2.2. Segmental Snapshot

2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

3.1. Market Lineage

3.1.1. Parent Market Analysis

3.1.2. Ancillary Market Analysis

3.2. Home Healthcare Market - Market Dynamics

3.2.1. Market Driver Analysis

3.2.1.1. Home healthcare as a cost-effective alternative

3.2.1.2. Hospital solution providers penetrating the home healthcare market

3.2.1.3. Geographical expansion of services by providers

3.2.1.4. Advancement in technology

3.2.2. Market Restraint Analysis

3.2.2.1. Lower remunerations

3.2.2.2. Shortage of skilled healthcare staff

3.2.2.3. Complicated reimbursement framework and reimbursement cuts

3.3. Business Environmental Tools Analysis: Home Healthcare Market

3.3.1. Porter’s Five Forces Analysis

3.3.2. PESTLE Analysis

Chapter 4. Home Healthcare Market: Component Estimates & Trend Analysis

4.1. Home Healthcare Market, By Component Key Takeaways

4.2. Home Healthcare Market: Component Movement & Market Share Analysis, 2023 & 2030

4.3. Services

4.3.1. Global Home Healthcare Services Market Estimates and Forecasts, 2021 - 2034 (USD Million)

4.3.2. Skilled home healthcare

4.3.2.1. Global skilled home healthcare services market estimates and forecasts, 2021 - 2034 (USD Million)

4.3.2.2. Nursing care

4.3.2.2.1. Global nursing care market estimates and forecasts, 2021 - 2034 (USD Million)

4.3.2.3. Physician primary care

4.3.2.3.1. Global physician primary care market estimates and forecasts, 2021 - 2034 (USD Million)

4.3.2.4. Physical/occupational/speech therapy

4.3.2.4.1. Global physical/occupational/speech therapy market estimates and forecasts, 2021 - 2034 (USD Million)

4.3.2.5. Hospice & palliative

4.3.2.5.1. Global hospice & palliative market estimates and forecasts, 2021 - 2034 (USD Million)

4.3.2.6. Nutritional support & infusion therapy

4.3.2.6.1. Global nutritional support market estimates and forecasts, 2021 - 2034 (USD Million)

4.3.2.7. Other skilled home healthcare

4.3.2.7.1. Global other skilled home healthcare services market estimates and forecasts, 2021 - 2034 (USD Million)

4.3.3. Unskilled Home Healthcare

4.3.3.1. Global unskilled home healthcare services market estimates and forecasts, 2021 - 2034 (USD Million)

4.4. Equipment

4.4.1. Global Home Healthcare Equipment Market Estimates and Forecasts, 2021 - 2034 (USD Million)

4.4.2. Therapeutic

4.4.2.1. Global therapeutic home healthcare equipment market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.2.2. Home respiratory therapy

4.4.2.2.1. Global home respiratory therapy market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.2.3. Home intravenous pumps

4.4.2.3.1. Global home IV pumps market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.2.4. Home dialysis equipment

4.4.2.4.1. Global home dialysis equipment market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.2.5. Insulin delivery

4.4.2.5.1. Global insulin delivery market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.2.6. Other therapeutic equipment

4.4.2.6.1. Global other therapeutic equipment market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.3. Diagnostic

4.4.3.1. Global diagnostic home healthcare equipment market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.3.2. Diabetic care unit

4.4.3.2.1. Global diabetic care unit market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.3.3. Blood pressure monitoring

4.4.3.3.1. Global blood pressure monitoring market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.3.4. Multi parameter diagnostics monitors

4.4.3.4.1. Global multi parameter diagnostics market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.3.5. Apnea and sleep monitors

4.4.3.5.1. Global apnea and sleep monitors market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.3.6. Home pregnancy and fertility kits

4.4.3.6.1. Global home pregnancy and fertility kits market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.3.7. Holter monitors

4.4.3.7.1. Global holter monitors market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.3.8. Heart rate meters

4.4.3.8.1. Global heart rate meter market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.3.9. Other diagnostic equipment

4.4.3.9.1. Global other diagnostic equipment market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.4. Mobility Assist Equipment

4.4.4.1. Global mobility assist equipment market estimates and forecasts, 2021 - 2034 (USD Million

4.4.4.2. Wheelchair

4.4.4.2.1. Global wheelchair market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.4.3. Home medical furniture

4.4.4.3.1. Global home medical furniture market estimates and forecasts, 2021 - 2034 (USD Million)

4.4.4.4. Walking assist devices

4.4.4.4.1. Global walking assist devices market estimates and forecasts, 2021 - 2034 (USD Million)

Chapter 5. Home Healthcare Market: Indication Estimates & Trend Analysis

5.1. Home Healthcare Market, By Indication: Key Takeaways

5.2. Home Healthcare Market: Indication Movement & Market Share Analysis, 2023 & 2030

5.3. Neurological & Mental Disorders

5.3.1. Global Neurological & Mental Disorders Market Estimates and Forecasts, 2021 - 2034 (USD Million)

5.4. Diabetes & Kidney Disorders

5.4.1. Global Diabetes & Kidney Disorders Market Estimates and Forecasts, 2021 - 2034 (USD Million)

5.5. Cancer

5.5.1. Global Cancer Market Estimates and Forecasts, 2021 - 2034 (USD Million)

5.6. Respiratory Disease & COPD

5.6.1. Global Respiratory Disease & COPD Market Estimates and Forecasts, 2021 - 2034 (USD Million)

5.7. Mobility Disorders

5.7.1. Global Mobility Disorders Market Estimates and Forecasts, 2021 - 2034 (USD Million)

5.8. Cardiovascular Disorder & Hypertension

5.8.1. Global Cardiovascular Disorder & Hypertension Market Estimates and Forecasts, 2021 - 2034 (USD Million)

5.9. Wound Care

5.9.1. Global Wound Care Market Estimates and Forecasts, 2021 - 2034 (USD Million)

5.10. Maternal Disorders

5.10.1. Global Maternal Disorders Market Estimates and Forecasts, 2021 - 2034 (USD Million)

5.11. Other Indications

5.11.1. Global Other Indications Market Estimates and Forecasts, 2021 - 2034 (USD Million)

Chapter 6. Home Healthcare Market: Regional Estimates & Trend Analysis

6.1. Regional Outlook

6.2. Home Healthcare Market by Region: Key Marketplace Takeaway

6.3. North America

6.3.1. North America Home Healthcare Market Estimates and Forecasts, 2021 - 2034 (USD Million)

6.3.2. U.S.

6.3.2.1. U.S. estimated disease burden by indication, 2019 -2022

6.3.2.2. Regulatory framework & reimbursement structure

6.3.2.3. Competitive scenario

6.3.2.4. U.S. home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.3.3. Canada

6.3.3.1. Canada estimated disease burden by indication, 2019 -2022

6.3.3.2. Regulatory framework & reimbursement structure

6.3.3.3. Competitive scenario

6.3.3.4. Canada home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.4. Europe

6.4.1. Europe Home Healthcare Market Estimates and Forecasts, 2021 - 2034 (USD Million)

6.4.2. UK

6.4.2.1. UK estimated disease burden by indication, 2019 -2022

6.4.2.2. Regulatory framework & reimbursement structure

6.4.2.3. Competitive scenario

6.4.2.4. UK home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.4.3. Germany

6.4.3.1. Germany estimated disease burden by indication, 2019 -2022

6.4.3.2. Regulatory framework & reimbursement structure

6.4.3.3. Competitive scenario

6.4.3.4. Germany home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.4.4. France

6.4.4.1. France estimated disease burden by indication, 2019 -2022

6.4.4.2. Regulatory framework & reimbursement structure

6.4.4.3. Competitive scenario

6.4.4.4. France home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.4.5. Italy

6.4.5.1. Italy estimated disease burden by indication, 2019 -2022

6.4.5.2. Regulatory framework & reimbursement structure

6.4.5.3. Competitive scenario

6.4.5.4. Italy Home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.4.6. Spain

6.4.6.1. Spain estimated disease burden by indication, 2019 -2022

6.4.6.2. Regulatory framework & reimbursement structure

6.4.6.3. Competitive scenario

6.4.6.4. Spain home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.4.7. Netherlands

6.4.7.1. Netherlands estimated disease burden by indication, 2019 -2022

6.4.7.2. Regulatory framework & reimbursement structure

6.4.7.3. Competitive scenario

6.4.7.4. Netherlands home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.4.8. Sweden

6.4.8.1. Sweden estimated disease burden by indication, 2019 -2022

6.4.8.2. Regulatory framework & reimbursement structure

6.4.8.3. Competitive scenario

6.4.8.4. Sweden home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.4.9. Ireland

6.4.9.1. Ireland estimated disease burden by indication, 2019 -2022

6.4.9.2. Regulatory framework & reimbursement structure

6.4.9.3. Competitive scenario

6.4.9.4. Ireland home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.4.10. Russia

6.4.10.1. Russia estimated disease burden by indication, 2019 -2022

6.4.10.2. Regulatory framework & reimbursement structure

6.4.10.3. Competitive scenario

6.4.10.4. Russia home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.4.11. Switzerland

6.4.11.1. Switzerland estimated disease burden by indication, 2019 -2022

6.4.11.2. Regulatory framework & reimbursement structure

6.4.11.3. Competitive scenario

6.4.11.4. Switzerland home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.4.12. Denmark

6.4.12.1. Denmark estimated disease burden by indication, 2019 -2022

6.4.12.2. Regulatory framework & reimbursement structure

6.4.12.3. Competitive scenario

6.4.12.4. Denmark home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.5. Asia Pacific

6.5.1. Asia Pacific Home Healthcare Market Estimates and Forecasts, 2021 - 2034 (USD Million)

6.5.2. Japan

6.5.2.1. Japan estimated disease burden by indication, 2019 -2022

6.5.2.2. Regulatory framework & reimbursement structure

6.5.2.3. Competitive scenario

6.5.2.4. Japan home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.5.3. China

6.5.3.1. China estimated disease burden by indication, 2019 -2022

6.5.3.2. Regulatory framework & reimbursement structure

6.5.3.3. Competitive scenario

6.5.3.4. China home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.5.4. India

6.5.4.1. India estimated disease burden by indication, 2019 -2022

6.5.4.2. Regulatory framework & reimbursement structure

6.5.4.3. Competitive scenario

6.5.4.4. India home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.5.5. Australia

6.5.5.1. Australia estimated disease burden by indication, 2019 -2022

6.5.5.2. Regulatory framework & reimbursement structure

6.5.5.3. Competitive scenario

6.5.5.4. Australia home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.5.6. South Korea

6.5.6.1. South Korea estimated disease burden by indication, 2019 -2022

6.5.6.2. Regulatory framework & reimbursement structure

6.5.6.3. Competitive scenario

6.5.6.4. South Korea home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.5.7. Singapore

6.5.7.1. Singapore estimated disease burden by indication, 2019 -2022

6.5.7.2. Regulatory framework & reimbursement structure

6.5.7.3. Competitive scenario

6.5.7.4. Singapore home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.5.8. Thailand

6.5.8.1. Thailand estimated disease burden by indication, 2019 -2022

6.5.8.2. Regulatory framework & reimbursement structure

6.5.8.3. Competitive scenario

6.5.8.4. Thailand home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.5.9. Philippines

6.5.9.1. Philippines estimated disease burden by indication, 2019 -2022

6.5.9.2. Regulatory framework & reimbursement structure

6.5.9.3. Competitive scenario

6.5.9.4. Philippines home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.5.10. Malaysia

6.5.10.1. Malaysia estimated disease burden by indication, 2019 -2022

6.5.10.2. Regulatory framework & reimbursement structure

6.5.10.3. Competitive scenario

6.5.10.4. Malaysia home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.5.11. New Zealand

6.5.11.1. New Zealand estimated disease burden by indication, 2019 -2022

6.5.11.2. Regulatory framework & reimbursement structure

6.5.11.3. Competitive scenario

6.5.11.4. New Zealand home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.6. Latin America

6.6.1. Latin America Home Healthcare Market Estimates and Forecasts, 2021 - 2034 (USD Million)

6.6.2. Brazil

6.6.2.1. Brazil estimated disease burden by indication, 2019 -2022

6.6.2.2. Regulatory framework & reimbursement structure

6.6.2.3. Competitive scenario

6.6.2.4. Brazil home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.6.3. Mexico

6.6.3.1. Mexico estimated disease burden by indication, 2019 -2022

6.6.3.2. Regulatory framework & reimbursement structure

6.6.3.3. Competitive scenario

6.6.3.4. Mexico home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.6.4. Argentina

6.6.4.1. Argentina estimated disease burden by indication, 2019 -2022

6.6.4.2. Regulatory framework & reimbursement structure

6.6.4.3. Competitive scenario

6.6.4.4. Argentina home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.7. Middle East & Africa

6.7.1. Middle East & Africa SWOT Analysis

6.7.2. Middle East & Africa Home Healthcare Market Estimates and Forecasts, 2021 - 2034 (USD Million)

6.7.3. South Africa

6.7.3.1. South Africa estimated disease burden by indication, 2019 -2022

6.7.3.2. Regulatory framework & reimbursement structure

6.7.3.3. Competitive scenario

6.7.3.4. South Africa home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.7.4. Saudi Arabia

6.7.4.1. Saudi Arabia estimated disease burden by indication, 2019 -2022

6.7.4.2. Regulatory framework & reimbursement structure

6.7.4.3. Competitive scenario

6.7.4.4. Saudi Arabia home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.7.5. UAE

6.7.5.1. UAE estimated disease burden by indication, 2019 -2022

6.7.5.2. Regulatory framework & reimbursement structure

6.7.5.3. Competitive scenario

6.7.5.4. UAE home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.7.6. Egypt

6.7.6.1. Egypt estimated disease burden by indication, 2019 -2022

6.7.6.2. Regulatory framework & reimbursement structure

6.7.6.3. Competitive scenario

6.7.6.4. Egypt home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

6.7.7. Oman

6.7.7.1. Oman estimated disease burden by indication, 2019 -2022

6.7.7.2. Regulatory framework & reimbursement structure

6.7.7.3. Competitive scenario

6.7.7.4. Oman home healthcare market estimates and forecasts, 2021 - 2034 (USD Million)

Chapter 7. Competitive Landscape

7.1. Company Categorization

7.2. Company Market Position Analysis: Suppliers

7.3. Company Market Position Analysis: Service Providers

7.4. Strategy Mapping

7.5. Company Profiles: Suppliers

7.5.1. McKesson Medical-Surgical Inc.

7.5.1.1. Overview

7.5.1.2. Financial Performance

7.5.1.3. Product Benchmarking

7.5.1.4. Strategic Initiatives

7.5.2. Fresenius Medical Care

7.5.2.1. Overview

7.5.2.2. Financial Performance

7.5.2.3. Product Benchmarking

7.5.2.4. Strategic Initiatives

7.5.3. Medline Industries, Inc.

7.5.3.1. Overview

7.5.3.2. Financial Performance

7.5.3.3. Product Benchmarking

7.5.3.4. Strategic Initiatives

7.5.4. Medtronic PLC

7.5.4.1. Overview

7.5.4.2. Financial Performance

7.5.4.3. Product Benchmarking

7.5.4.4. Strategic Initiatives

7.5.5. 3M Healthcare

7.5.5.1. Overview

7.5.5.2. Financial Performance

7.5.5.3. Product Benchmarking

7.5.5.4. Strategic Initiatives

7.5.6. Baxter International Inc.

7.5.6.1. Overview

7.5.6.2. Financial Performance

7.5.6.3. Product Benchmarking

7.5.6.4. Strategic Initiatives

7.5.7. B. Braun Melsungen AG

7.5.7.1. Overview

7.5.7.2. Financial Performance

7.5.7.3. Product Benchmarking

7.5.7.4. Strategic Initiatives

7.5.8. Arkray, Inc.

7.5.8.1. Overview

7.5.8.2. Financial Performance

7.5.8.3. Product Benchmarking

7.5.8.4. Strategic Initiatives

7.5.9. F. Hoffmann-La Roche AG

7.5.9.1. Overview

7.5.9.2. Financial Performance

7.5.9.3. Product Benchmarking

7.5.9.4. Strategic Initiatives

7.5.10. Becton, Dickinson and Company

7.5.10.1. Overview

7.5.10.2. Financial Performance

7.5.10.3. Product Benchmarking

7.5.10.4. Strategic Initiatives

7.5.11. Acelity L.P.

7.5.11.1. Overview

7.5.11.2. Financial Performance

7.5.11.3. Product Benchmarking

7.5.11.4. Strategic Initiatives

7.5.12. Hollister Inc.

7.5.12.1. Overview

7.5.12.2. Financial Performance

7.5.12.3. Product Benchmarking

7.5.12.4. Strategic Initiatives

7.5.13. ConvaTec Group PLC

7.5.13.1. Overview

7.5.13.2. Financial Performance

7.5.13.3. Product Benchmarking

7.5.13.4. Strategic Initiatives

7.5.14. Molnlycke Health Care

7.5.14.1. Overview

7.5.14.2. Financial Performance

7.5.14.3. Product Benchmarking

7.5.14.4. Strategic Initiatives

7.6. Company Profile: Service Providers

7.6.1. Brookdale Senior Living, Inc.

7.6.1.1. Overview

7.6.1.2. Financial Performance

7.6.1.3. Service Benchmarking

7.6.1.4. Strategic Initiatives

7.6.2. Home Health Services Ltd.

7.6.2.1. Overview

7.6.2.2. Financial Performance

7.6.2.3. Service Benchmarking

7.6.2.4. Strategic Initiatives

7.6.3. Sunrise Carlisle, LP

7.6.3.1. Overview

7.6.3.2. Financial Performance

7.6.3.3. Service Benchmarking

7.6.3.4. Strategic Initiatives

7.6.4. Extendicare, Inc.

7.6.4.1. Overview

7.6.4.2. Financial Performance

7.6.4.3. Service Benchmarking

7.6.4.4. Strategic Initiatives

7.6.5. Care UK Limited

7.6.5.1. Overview

7.6.5.2. Financial Performance

7.6.5.3. Service Benchmarking

7.6.5.4. Strategic Initiatives

7.6.6. Senior Care Centers of America

7.6.6.1. Overview

7.6.6.2. Financial Performance

7.6.6.3. Service Benchmarking

7.6.6.4. Strategic Initiatives

7.6.7. Genesis Healthcare Corp.

7.6.7.1. Overview

7.6.7.2. Financial Performance

7.6.7.3. Service Benchmarking

7.6.7.4. Strategic Initiatives

7.6.8. Sompo Holdings, Inc.

7.6.8.1. Overview

7.6.8.2. Financial Performance

7.6.8.3. Service Benchmarking

7.6.8.4. Strategic Initiatives

7.6.9. Kindred Healthcare, Inc.

7.6.9.1. Overview

7.6.9.2. Financial Performance

7.6.9.3. Service Benchmarking

7.6.9.4. Strategic Initiatives

7.6.10. Home Instead Senior Care, Inc.

7.6.10.1. Overview

7.6.10.2. Financial Performance

7.6.10.3. Service Benchmarking

7.6.10.4. Strategic Initiatives

Chapter 8. Key Recommendations/Key Market Insights